Predictive Oncology Inc. (POAI)
NASDAQ: POAI · IEX Real-Time Price · USD
1.650
+0.220 (15.38%)
At close: May 1, 2024, 4:00 PM
1.620
-0.030 (-1.82%)
After-hours: May 1, 2024, 7:39 PM EDT
Predictive Oncology Revenue
In the year 2023, Predictive Oncology had annual revenue of $1.78M with 18.24% growth. Revenue in the quarter ending December 31, 2023 was $335.03K, a -7.82% decrease year-over-year.
Revenue (ttm)
$1.78M
Revenue Growth
+18.24%
P/S Ratio
3.77
Revenue / Employee
$52,356
Employees
34
Market Cap
6.70M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.78M | 274.63K | 18.24% |
Dec 31, 2022 | 1.51M | 84.78K | 5.97% |
Dec 31, 2021 | 1.42M | 168.41K | 13.45% |
Dec 31, 2020 | 1.25M | -159.29K | -11.28% |
Dec 31, 2019 | 1.41M | -90.00 | -0.01% |
Dec 31, 2018 | 1.41M | 756.82K | 115.57% |
Dec 31, 2017 | 654.84K | 198.34K | 43.45% |
Dec 31, 2016 | 456.50K | -197.86K | -30.24% |
Dec 31, 2015 | 654.35K | -297.21K | -31.23% |
Dec 31, 2014 | 951.56K | 483.43K | 103.27% |
Dec 31, 2013 | 468.13K | 279.35K | 147.98% |
Dec 31, 2012 | 188.77K | 92.14K | 95.34% |
Dec 31, 2011 | 96.64K | 96.35K | 33,454.51% |
Dec 31, 2010 | 288.00 | -15.45K | -98.17% |
Dec 31, 2009 | 15.74K | - | - |
Dec 31, 2008 | 0 | - | - |
Dec 31, 2007 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Healthcare Triangle | 33.20M |
Regional Health Properties | 17.16M |
Soligenix | 839.36K |
Sonnet BioTherapeutics Holdings | 129.18K |
Silo Pharma | 72.10K |
POAI News
- 7 days ago - Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting - GlobeNewsWire
- 4 weeks ago - Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Predictive Oncology to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 months ago - Predictive Oncology to Participate in Upcoming San Francisco Conferences - GlobeNewsWire
- 6 months ago - Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update - GlobeNewsWire
- 6 months ago - Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital - GlobeNewsWire
- 9 months ago - Predictive Oncology Reports Second Quarter 2023 Financial Results and Provides Business Update - GlobeNewsWire
- 9 months ago - Predictive Oncology to Report Second Quarter 2023 Financial Results and Host Conference Call and Webcast on Thursday, August 10, 2023 - GlobeNewsWire